CX3CR1 and neoplasm: Further, blockade of TREM2 expressed on macrophages induced a decline in CX3CR1+CD206+ macrophages and promoted macrophages expressing immunostimulatory molecules, with anti-TREM2 monoclonal antibody (mAb) dampening tumor growth and augmenting anti-PD-1 efficacy42.